Advanced search
Publication Cover
Modern Rheumatology Volume 29, 2019 - Issue 3
Journal homepage
3,493
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Efficacy and safety of intravenous belimumab in Japanese patients with systemic lupus erythematosus: A subgroup analysis of a phase 3 randomized placebo-controlled trial

Yoshiya TanakaThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health Japan, Kitakyushu, Japan; Correspondence[email protected]
View further author information
,
Damon BassGlaxoSmithKline, Philadelphia, PA, USA; View further author information
,
Myron ChuGlaxoSmithKline, Philadelphia, PA, USA; View further author information
,
Sally EggintonGlaxoSmithKline, Stevenage, UK; View further author information
,
Beulah JiClinical Development, GlaxoSmithKline R&D, Uxbridge, UK; View further author information
,
Herbert StruemperQuantitative Clinical Development, PAREXEL, Durham, NC, USAView further author information
&
David RothGlaxoSmithKline, Philadelphia, PA, USA; View further author information
 show all
Pages 452-460 | Received 24 Jan 2018, Accepted 02 May 2018, Published online: 20 Jul 2018

Related Research Data

Efficacy and safety of intravenous belimumab in Japanese patients with systemic lupus erythematosus: A subgroup analysis of a phase 3 randomized placebo-controlled trial
Source: Taylor & Francis
Efficacy and safety of intravenous belimumab in Japanese patients with systemic lupus erythematosus: A subgroup analysis of a phase 3 randomized placebo-controlled trial
Source: Figshare

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.